Apoptosis modulation in hepatocytes

"Apoptosis modulation in hepatocytes" refers broadly to the regulation of programmed cell death processes within liver parenchymal cells. Hepatocyte apoptosis is central to the pathogenesis and progression of many acute and chronic liver diseases including steatohepatitis, fibrosis, cirrhosis, and cancer. The apoptotic process is regulated by both extrinsic pathways—primarily through activation of death receptors such as tumor necrosis factor receptor 1 (TNFR1) by ligands like TNFα—and intrinsic mitochondrial pathways involving Bcl‑2 family proteins. Key molecular events include formation of signaling complexes that activate initiator caspases such as caspase‑8 and effector caspases like caspase‑3. Crosstalk with survival signals mediated by NF‑κB also determines whether a pro-apoptotic stimulus leads to cell death or survival. Modulation can occur at multiple levels including transcriptional regulation by factors such as YAP/TAZ from the Hippo pathway—which can inhibit both intrinsic and extrinsic apoptotic cascades—or through pharmacologic intervention targeting these signaling nodes[1][2][3]. Note on correctness: This entry does not correspond to a single molecule or canonical therapeutic target but rather describes an entire biological process involving numerous molecular players. For structured data purposes it should be flagged as incorrect for use as a canonical drug discovery target name—it lacks specificity required for mapping drugs/mechanisms/biomarkers directly[2][3].